The High Diagnostic Yield of Prenatal Exome Sequencing Followed by 3400 Gene Panel Analysis in 629 Ongoing Pregnancies With Ultrasound Anomalies
- PMID: 39349395
- DOI: 10.1002/pd.6676
The High Diagnostic Yield of Prenatal Exome Sequencing Followed by 3400 Gene Panel Analysis in 629 Ongoing Pregnancies With Ultrasound Anomalies
Abstract
Background: The aim of this study was to evaluate the diagnostic yield of routine exome sequencing (ES) in fetuses with ultrasound anomalies.
Methods: We performed a retrospective analysis of the ES results of 629 fetuses with isolated or multiple anomalies referred in 2019-2022. Variants in a gene panel consisting of approximately 3400 genes associated with multiple congenital anomalies and/or intellectual disability were analyzed. We used trio analysis and filtering for de novo variants, compound heterozygous variants, homozygous variants, X-linked variants, variants in imprinted genes, and known pathogenic variants.
Results: Pathogenic and likely pathogenic variants (class five and four, respectively) were identified in 14.0% (88/629, 95% CI 11.5%-16.9%) of cases. In the current cohort, the probability of detecting a monogenetic disorder was ∼1:7 (88/629, 95% CI 1:8.7-1:5.9), ranging from 1:9 (49/424) in cases with one major anomaly to 1:5 (32/147) in cases with multiple system anomalies.
Conclusions: Our results indicate that a notable number of fetuses (1:7) with ultrasound anomalies and a normal chromosomal microarray have a (likely) pathogenic variant that can be detected through prenatal ES. These results warrant implementation of exome sequencing in selected cases, including those with an isolated anomaly on prenatal ultrasound.
© 2024 The Author(s). Prenatal Diagnosis published by John Wiley & Sons Ltd.
References
-
- K. G. Monaghan, N. T. Leach, D. Pekarek, P. Prasad, and N. C. Rose, “The Use of Fetal Exome Sequencing in Prenatal Diagnosis: A Points to Consider Document of the American College of Medical Genetics and Genomics (ACMG),” Genetics in Medicine 22, no. 4 (April 2020): 675–680, https://doi.org/10.1038/s41436‐019‐0731‐7.
-
- J. Lord, D. J. McMullan, R. Y. Eberhardt, et al., “Prenatal Exome Sequencing Analysis in Fetal Structural Anomalies Detected by Ultrasonography (PAGE): A Cohort Study,” Lancet 393, no. 10173 (January 2019): 747–757, https://doi.org/10.1016/S0140‐6736(18)31940‐8.
-
- S. Petrovski, V. Aggarwal, J. L. Giordano, et al., “Whole‐Exome Sequencing in the Evaluation of Fetal Structural Anomalies: A Prospective Cohort Study,” Lancet 393, no. 10173 (February 2019): 758–767, https://doi.org/10.1016/S0140‐6736(18)32042‐7.
-
- K. Diderich, M. Joosten, L. Govaerts, et al., “Is It Feasible to Select Fetuses for Prenatal WES Based on the Prenatal Phenotype?,” Prenatal Diagnosis 39, no. 11 (October 2019): 1039–1040, https://doi.org/10.1002/pd.5522.
-
- K. E. M. Diderich, K. Romijn, M. Joosten, et al., “The Potential Diagnostic Yield of Whole Exome Sequencing in Pregnancies Complicated by Fetal Ultrasound Anomalies,” Acta Obstetricia et Gynecologica Scandinavica 100, no. 6 (2021): 1106–1115, https://doi.org/10.1111/aogs.14053.
MeSH terms
LinkOut - more resources
Full Text Sources